Osteoarthritis of the knee is a common and often painful condition affecting millions worldwide, especially older adults. As weight loss medications like Ozempic continue to gain traction for their ...

Topline results were announced from a phase 3 clinical trial evaluating subcutaneous semaglutide in obesity and knee osteoarthritis.

It seems like every day a new study emerges linking Ozempic and similar drugs to new health benefits. Ozempic is part of a drug class known as GLP-1 medications, which mimic gut hormones that help ...

Medications like Ozempic and Wegovy, which are used to treat type 2 diabetes and boost weight loss, may also help reduce knee ...

The study reviewed 407 people with obesity and knee osteoarthritis taking semaglutide, the active component of Ozempic and Wegovy, or a placebo over 68 weeks. At the study's onset, the average amount ...

New research suggests that Ozempic may be a helpful treatment for knee pain caused by osteoarthritis. Here’s what you need to know.

“There are genetic aspects, physical aspects, and inflammatory aspects,” he says. Ozempic can help people to lose weight, ...

Semaglutide, the active ingredient in Ozempic ... obstructive sleep apnea, and osteoarthritis. If you’re concerned, consult ...

The results of a clinical trial published this week found that the active ingredient in the diabetes and weight loss medications Ozempic and Wegovy was linked with a near halving of reported pain ...

A clinical trial funded by Novo Nordisk found that Ozempic (semaglutide) was linked with reduced pain among patients with ...

Novo Nordisk's (NVO) semaglutide, marketed as Wegovy for obesity, shows promise in reducing joint disease symptoms in ...

HealthDay News — For individuals with obesity and knee osteoarthritis, once-weekly semaglutide yields greater reductions in body weight and pain related to knee osteoarthritis than placebo, according ...